Biocept (BIOC) Misses Q2 EPS by 14c

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.14), $0.14 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $12 million versus the consensus estimate of $17.76 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Deutsche Bank Starts Associated British Foods (ABF:LN) (ASBFY) at Hold
• Copart (CPRT) Misses Q4 EPS by 4c